TROG Cancer Research
Members Login   CQMS Login  

Closed symptom management trials

TROG 11.02 (SCORAD III) - this randomised clinical trial is comparing two radiation therapy regimens to see how well they work in treating patients with metastatic spinal cord compression.

Primary sponsor: University College London (UCL)
Collaborating group: TROG


Completed trials

TROG 04.01 - A Paired Double Blind Randomised Comparison of Cavilon Durable Barrier Cream (CDBC) to 10% Glycerine (“Sorbolene”) Cream in the Prophylactic Management of Post-Mastectomy Irradiation Skin Care.

TROG 03.08 - A phase III international randomized trial of single versus multiple fractions for re-irradiation of painful bone metastases

TROG 01.05 - A Pilot Randomised Controlled Trial of Dexamethasone 96mg Versus 16mg Per Day for Malignant Spinal Cord Compression Treated by Radiotherapy - TROG SuperDex Pilot

TROG 98.04 - Phase II Study Examining the Efficacy of Short Fractionation Radiotherapy for the Palliation of Liver Metastases

TROG 96.05 - A Prospective Randomised Trial of Single Fraction Verses Fractionated Radiotherapy of Neuropathic Pain Due to Bone Metastases

TROG 96.04 - Phase III Comparison of Radiotherapy with Glucocorticoid Steroid Support for the Palliation of Liver Metastases

TROG 95.02 - A Phase III Double-Blind Randomised Trial of Rectal Sucralfate Suspension in the Treatment of Radiation Proctitis

We are thankful to our 14,500 patients who have participated in our research. Please continue the generous support.